I agree that this site is using cookies. You can find further informations here.
X
Werlenius, K.
16  results:
Search for persons X
?
1

What predicts survival in glioblastoma? A population-based ..:

Fekete, B. ; Werlenius, K. ; Tisell, M....
Frontiers in Surgery.  10 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome a..:

Lindholm, C. ; Tobiasson, M. ; Pandzic, T....
Leukemia Research.  128 (2023)  - p. 107227 , 2023
Link: https://doi.org/10.1016/..
 
?
3

What predicts survival in glioblastoma? A population-based ..:

Fekete, B ; Werlenius, K ; Tisell, M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498299/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

What predicts survival in glioblastoma? A population-based ..:

B. Fekete ; K. Werlenius ; M. Tisell...
https://www.frontiersin.org/articles/10.3389/fsurg.2023.1249366/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
5

S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRAN..:

Tobiasson, M. ; Pandzic, T. ; Illman, J....
HemaSphere.  6 (2022)  - p. 68-69 , 2022
Link: https://doi.org/10.1097/..
 
?
6

S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRAN..:

M. Tobiasson ; T. Pandzic ; J. Illman...
http://journals.lww.com/10.1097/01.HS9.0000843560.87168.a9.  , 2022
Link: https://doi.org/10.1097/..
 
?
7

A randomized phase II trial of efficacy and safety of the i..:

Werlenius, Katja ; Stragliotto, Giuseppe ; Strandeus, Michael...
Neuro-Oncology Advances.  3 (2021)  1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
8

A randomized phase II trial of efficacy and safety of the i..:

Werlenius, Katja ; Stragliotto, Giuseppe ; Strandeus, Michael...
Neuro-Oncology Advances, 2021, 3:1,.  , 2021
Link: http://urn.kb.se/resolve..
 
?
9

P01.090Patterns of care and clinical outcome in patients wi..:

Werlenius, K ; Fekete Rydenhag, B ; Blomstrand, M...
Neuro-Oncology.  20 (2018)  suppl_3 - p. iii251-iii251 , 2018
Link: https://doi.org/10.1093/..
 
?
10

P01.151Gender differences in glioma - findings from the Swe..:

Malmström, A ; Åkesson, L ; Asklund, T...
Neuro-Oncology.  20 (2018)  suppl_3 - p. iii267-iii267 , 2018
Link: https://doi.org/10.1093/..
 
?
11

P05.43Proton therapy of CNS tumors:

Witt Nyström, P ; Werlenius, K ; Blomstrand, M.
Neuro-Oncology.  20 (2018)  suppl_3 - p. iii312-iii313 , 2018
Link: https://doi.org/10.1093/..
 
?
12

Impact of killer-immunoglobulin-like receptor and human leu..:

Bernson, E ; Hallner, A ; Sander, F E...
Leukemia.  31 (2017)  12 - p. 2552-2559 , 2017
Link: https://doi.org/10.1038/..
 
?
13

P06.10 Dose-response relationship of ALECSAT immunotherapy ..:

Werlenius, K. ; Wenger, A. ; Blomstrand, M....
Neuro-Oncology.  19 (2017)  suppl_3 - p. iii51-iii51 , 2017
Link: https://doi.org/10.1093/..
 
?
14

Impact of killer-immunoglobulin-like receptor and human leu..:

Bernson, E ; Hallner, A ; Sander, F. E...
info:eu-repo/semantics/altIdentifier/pmid/28529313.  , 2017
Link: http://hdl.handle.net/11..
 
?
15

Prognostic factors for glioblastoma patients - a clinical p..:

Fekete, B. ; Werlenius, K. ; Örndal, C..
Acta Neurologica Scandinavica.  133 (2015)  6 - p. 434-441 , 2015
Link: https://doi.org/10.1111/..
 
1-15